オリゴヌクレオチド合成市場：製品（装置、リンカー＆アダプター、プローブ）、タイプ（カスタム、設計済み）、用途、エンドユーザー別-2023-2030年の世界予測

オリゴヌクレオチド合成の世界市場は大きく成長し、2023年には102億9,579万米ドル、CAGR 20.04%と予測され、2030年には374億1,836万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のオリゴヌクレオチド合成市場を評価するために不可欠です。ビジネス戦略と製品満足度の主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.オリゴヌクレオチド合成の世界市場規模および予測は？

2.予測期間中、世界のオリゴヌクレオチド合成市場を形成するCOVID-19の阻害要因と影響は？

3.オリゴヌクレオチド合成の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.オリゴヌクレオチド合成の世界市場における競争戦略は？

5.オリゴヌクレオチド合成の世界市場における技術動向と規制の枠組みは？

6.オリゴヌクレオチド合成の世界市場における主要ベンダーの市場シェアは？

7.オリゴヌクレオチド合成の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の蔓延と創薬への注目の高まり
    • 分子診断および臨床応用における合成オリゴヌクレオチドの使用の増加
    • 製薬およびバイオテクノロジー調査への多額の投資
  • 抑制要因
    • オリゴヌクレオチドの製造コストが高い
  • 機会
    • オリゴヌクレオチド合成の改善と進歩
    • オリゴヌクレオチドの増産に向けた戦略的提携
  • 課題
    • 大規模なオリゴヌクレオチド合成に伴う合併症
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 オリゴヌクレオチド合成市場：製品別

• 装置
• リンカーとアダプター
• プローブ
• 試薬と消耗品
• サービス
• 合成オリゴヌクレオチド

第7章 オリゴヌクレオチド合成市場：タイプ別

• カスタム
• 設計済み

第8章 オリゴヌクレオチド合成市場：用途別

• 診断
• 調査
• 治療用

第9章 オリゴヌクレオチド合成市場：エンドユーザー別

• 学術調査機関
• CROとCMO
• 診断研究所と病院
• 製薬およびバイオテクノロジー企業

第10章 南北アメリカのオリゴヌクレオチド合成市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のオリゴヌクレオチド合成市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのオリゴヌクレオチド合成市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別
  • 契約、コラボレーション、パートナーシップ
  • 新製品発売と機能強化
  • 投資、資金調達
  • 受賞・表彰・拡大

第14章 掲載企業一覧

第15章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. OLIGONUCLEOTIDE SYNTHESIS MARKET RESEARCH PROCESS
• FIGURE 2. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2022 VS 2030
• FIGURE 3. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
• FIGURE 5. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 6. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 7. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
• FIGURE 8. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. OLIGONUCLEOTIDE SYNTHESIS MARKET DYNAMICS
• FIGURE 10. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. OLIGONUCLEOTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. OLIGONUCLEOTIDE SYNTHESIS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 5. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY LINKERS & ADAPTOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PROBES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGONUCLEOTIDES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 12. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CUSTOM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRE-DESIGNED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 15. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 19. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CROS & CMOS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES & HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 133. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. POLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. POLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 149. POLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. POLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 152. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 153. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. OLIGONUCLEOTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 192. OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 193. OLIGONUCLEOTIDE SYNTHESIS MARKET LICENSE & PRICING

The Global Oligonucleotide Synthesis Market is forecasted to grow significantly, with a projected USD 10,295.79 million in 2023 at a CAGR of 20.04% and expected to reach a staggering USD 37,418.36 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Oligonucleotide Synthesis Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Oligonucleotide Synthesis Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Equipment, Linkers & Adaptor, Probes, Reagents & Consumables, Services, and Synthesized Oligonucleotides. The Equipment commanded largest market share of 19.12% in 2022, followed by Synthesized Oligonucleotides.

Based on Type, market is studied across Custom and Pre-designed. The Custom commanded largest market share of 62.34% in 2022, followed by Pre-designed.

Based on Application, market is studied across Diagnostic, Research, and Therapeutic. The Research commanded largest market share of 48.57% in 2022, followed by Diagnostic.

Based on End-User, market is studied across Academic Research Institutes, CROs & CMOs, Diagnostic Laboratories & Hospitals, and Pharmaceutical & Biotechnology Companies. The CROs & CMOs commanded largest market share of 37.25% in 2022, followed by Pharmaceutical & Biotechnology Companies.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 43.72% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Oligonucleotide Synthesis Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Oligonucleotide Synthesis Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Oligonucleotide Synthesis Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Oligonucleotide Synthesis Market?

4. What is the competitive strategic window for opportunities in the Global Oligonucleotide Synthesis Market?

5. What are the technology trends and regulatory frameworks in the Global Oligonucleotide Synthesis Market?

6. What is the market share of the leading vendors in the Global Oligonucleotide Synthesis Market?

7. What modes and strategic moves are considered suitable for entering the Global Oligonucleotide Synthesis Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Oligonucleotide Synthesis Market, by Product, 2022 vs 2030
• 4.3. Oligonucleotide Synthesis Market, by Type, 2022 vs 2030
• 4.4. Oligonucleotide Synthesis Market, by Application, 2022 vs 2030
• 4.5. Oligonucleotide Synthesis Market, by End-User, 2022 vs 2030
• 4.6. Oligonucleotide Synthesis Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of chronic diseases and growing focus on drug discovery
    • 5.1.1.2. Rising usage of synthesized oligonucleotides in molecular diagnostics and clinical applications
    • 5.1.1.3. Significant investments in pharmaceutical and biotechnology research
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of oligonucleotides production
  • 5.1.3. Opportunities
    • 5.1.3.1. Improvements and advances in oligonucleotide synthesis
    • 5.1.3.2. Strategic alliances for increasing production of oligonucleotides
  • 5.1.4. Challenges
    • 5.1.4.1. Complications associated with large scale oligonucleotide synthesis
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Oligonucleotide Synthesis Market, by Product

• 6.1. Introduction
• 6.2. Equipment
• 6.3. Linkers & Adaptor
• 6.4. Probes
• 6.5. Reagents & Consumables
• 6.6. Services
• 6.7. Synthesized Oligonucleotides

7. Oligonucleotide Synthesis Market, by Type

• 7.1. Introduction
• 7.2. Custom
• 7.3. Pre-designed

8. Oligonucleotide Synthesis Market, by Application

• 8.1. Introduction
• 8.2. Diagnostic
• 8.3. Research
• 8.4. Therapeutic

9. Oligonucleotide Synthesis Market, by End-User

• 9.1. Introduction
• 9.2. Academic Research Institutes
• 9.3. CROs & CMOs
• 9.4. Diagnostic Laboratories & Hospitals
• 9.5. Pharmaceutical & Biotechnology Companies

10. Americas Oligonucleotide Synthesis Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Oligonucleotide Synthesis Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Oligonucleotide Synthesis Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player
  • 13.3.1. Agreement, Collaboration, & Partnership
    • 13.3.1.1. UK Partnership Set To Revolutionize Oligonucleotide Manufacture
    • 13.3.1.2. Aurisco Collaborates With Cytiva To Build First Oligo Flexfactory In China
  • 13.3.2. New Product Launch & Enhancement
    • 13.3.2.1. Codexis Unveils ECO Synthesis Platform for Large-Scale RNAi Therapeutics Production at TIDES USA
  • 13.3.3. Investment & Funding
    • 13.3.3.1. CatSci Invests In Oligonucleotides Capability For Rare Diseases
  • 13.3.4. Award, Recognition, & Expansion
    • 13.3.4.1. GenScript Expands Peptide and Oligonucleotide Production Facility in China
    • 13.3.4.2. CordenPharma Announces Entry into Oligonucleotide Manufacturing with Two-phase Investment at CordenPharma Colorado2nd May 2023
    • 13.3.4.3. Oligo Factory Opens New State-of-the-Art Oligo Manufacturing Facility
    • 13.3.4.4. Agilent Will Double Oligonucleotide Capacity
    • 13.3.4.5. WuXi STA Opens Large-Scale Oligo and Peptide Manufacturing Facility

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing